Catalyst Wire Dossier Catalyst Wire Dossier

Tasisulam-sodium

tasisulam · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tasisulam-sodium, covering 2018-07-17 to 2018-07-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma [Phase 3]

See pricing